PMC:7696151 / 10126-10315
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 300 | 4-12 | Species | denotes | patients | Tax:9606 |
| 314 | 58-68 | Chemical | denotes | zidovudine | MESH:D015215 |
| 315 | 70-73 | Chemical | denotes | ZDV | MESH:D015215 |
| 316 | 76-96 | Chemical | denotes | 2′,3′-dideoxyinosine | MESH:D016049 |
| 317 | 101-122 | Chemical | denotes | 2′,3′-dideoxycytidine | MESH:D016047 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T85 | 0-189 | Sentence | denotes | All patients treated with antiretroviral therapy (HAART = zidovudine (ZDV), 2′,3′-dideoxyinosine, or 2′,3′-dideoxycytidine) and stopped taking it four weeks before the clinical trial start. |